Pendarvis Christiane 4

What Happened

• Christiane Pendarvis, a director of Hims & Hers Health, Inc. (HIMS), reported the conversion/exercise of a derivative into 15,211 shares on 2026-03-13. The filing shows 15,211 shares as "Acquired" (exercise/conversion) and a corresponding 15,211 shares as "Disposed" at $0.00 (derivative).
• The acquisition line lists price as N/A (no cash paid reported) and the disposal line shows $0.00 total value. The filing does not report a cash purchase or sale amount tied to these entries.

Key Details

• Transaction date: March 13, 2026; Form 4 filed March 17, 2026 (filed within the SEC two-business-day window).
• Reported amounts: 15,211 shares acquired via exercise/conversion; 15,211 shares disposed at $0.00.
• Shares owned after transaction: not specified in the provided filing.
• Footnotes: These shares relate to Restricted Stock Units (RSUs) that convert 1:1 into Class A common stock. The RSUs vest over three years: 1/3 on Mar 15, 2024; 1/3 on Mar 15, 2025; and 1/3 on Mar 15, 2026.
• Note on reporting: The matching acquire/dispose lines for the same share count and a $0.00 disposal often reflect conversion and administrative settlement steps (e.g., issuance or withholding), but the filing itself does not state the specific administrative reason.

Context

• This was a derivative conversion of RSUs rather than an open-market buy or sale. Such conversions typically reflect scheduled vesting and issuance of shares rather than a directional trade signal by the insider.
• No cash proceeds or open-market sale is reported here; retail investors should treat this as an administrative/vesting-related transaction unless further filings indicate a sale.